Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-19

Clinical Trial Update: A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation. [Phase 3]

View source ↗

Summary

Phase 3 study assessing the effectiveness and safety of dapoxetine for premature ejaculation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapoxetine (dapoxetine)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Ejaculation | Phase 3 | Status: COMPLETED